Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

Older adults taking GLP-1 receptor agonists, primarily semaglutide (Rybelsus, Ozempic, Wegovy), had a small uptick in their ...

In this randomized controlled trial, oral semaglutide significantly reduced the risk of adverse cardiovascular events in ...